Market Research Reports and Industry Reports

Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sopharma AD (Sopharma) carries out the development, manufacturing and commercialization of medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary vaccines; infusion solutions; hemodialysis concentrates; medical disposable products; and injection molded products. It also performs research and development and implementation activities catering to the areas of phytochemistry, chemistry and pharmacy. Its key product portfolio consists of carsil, tempalgin, tabex, tribestan, broncholytin, analgin, nivalin and methylprednisolone. Geographically, the company distributes its products in Poland, Russia, Ukraine, Turkey, Georgia, Serbia, Belarus and other countries. Sopharma is headquartered in Sofia, Bulgaria.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Sopharma AD - Key Facts 5
Sopharma AD - Key Employees 6
Sopharma AD - Key Employee Biographies 7
Sopharma AD - Major Products and Services 8
Sopharma AD - History 9
Sopharma AD - Company Statement 11
Sopharma AD - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Joint Venture 13
Section 2 Company Analysis 14
Sopharma AD - Business Description 14
Sopharma AD - SWOT Analysis 15
SWOT Analysis - Overview 15
Sopharma AD - Strengths 15
Sopharma AD - Weaknesses 16
Sopharma AD - Opportunities 17
Sopharma AD - Threats 18
Sopharma AD - Key Competitors 19
Section 3 Company Financial Ratios 20
Financial Ratios - Capital Market Ratios 20
Financial Ratios - Annual Ratios 21
Performance Chart 24
Financial Performance 24
Financial Ratios - Interim Ratios 25
Financial Ratios - Ratio Charts 26
Section 4 Companys Lifesciences Financial Deals and Alliances 27
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Sopharma AD, Recent Deals Summary 29
Section 5 Appendix 30
Methodology 30
Ratio Definitions 30
About GlobalData 34
Contact Us 34
Disclaimer 34

List Of Tables


Sopharma AD, Key Facts 5
Sopharma AD, Key Employees 6
Sopharma AD, Key Employee Biographies 7
Sopharma AD, Major Products and Services 8
Sopharma AD, History 9
Sopharma AD, Subsidiaries 12
Sopharma AD, Joint Venture 13
Sopharma AD, Key Competitors 19
Sopharma AD, Ratios based on current share price 20
Sopharma AD, Annual Ratios 21
Sopharma AD, Annual Ratios (Cont...1) 22
Sopharma AD, Annual Ratios (Cont...2) 23
Sopharma AD, Interim Ratios 25
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 28
Sopharma AD, Recent Deals Summary 29
Currency Codes 30
Capital Market Ratios 30
Equity Ratios 31
Profitability Ratios 31
Cost Ratios 32
Liquidity Ratios 32
Leverage Ratios 33
Efficiency Ratios 33

List Of Figures


Sopharma AD, Performance Chart (2012 - 2016) 24
Sopharma AD, Ratio Charts 26
Sopharma AD, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 27
Sopharma AD, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 28

Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review

Sopharma AD (3JR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125View Report

Sopharma AD in Consumer Health (Bulgaria)

Sopharma is Bulgarias largest pharmaceuticals manufacturer, and was ranked second in consumer health in 2016. It has 15 manufacturing operations in Bulgaria licensed according to GMP, one pharmaceutical factory in

USD 150View Report

Sopharma AD in Consumer Health (Bulgaria)

Sopharma is Bulgarias largest pharmaceuticals manufacturer, and was ranked second in consumer health in 2016. It has 15 manufacturing operations in Bulgaria licensed according to GMP, one pharmaceutical factory in

USD 150View Report

Sopharma AD (3JR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sopharma AD (Sopharma) carries out the development, manufacturing and commercialization of medicinal substances and finished dosage forms. The company focuses on the production of pharmaceutical products; substances and preparations; veterinary

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Aug 2017
No. of Pages :34
Country :Bulgaria
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube
paykasa bozdurma,paykasa bozdurma,astropay bozdurma,paykasa,paykasa,paykasa bozdurma,paykasa,astropay bozdurma,justin kart,bitcoin bozdurma,paykasa bozum,paykasa kart bozdurma,
beylikduzu escort,bahçeşehir escort,escort istanbul,istanbul escort,sex hikayeleri,pendik escort,
pedalebiellese.com,
istanbul escort bayan,besiktas escort,maltepe escort,kadikoy escort bayan,tekirdag escort bayan,findikzade escort,antalya escort bayan,ankara escort bayan,
Böcek İlaçlama,şehirler arası nakliyat,şehirler arası evden eve nakliyat,ofis taşıma,gebze evden eve nakliyat,kadıköy evden eve nakliyat,istanbul evden eve nakliyat,epoksi zemin,
ankara escort,ankara escort,ankara escort,
tipobet,
seo teknikleri wordpress ücretsiz tema istanbul sexs shop hacklink e sigara sexs shop